[1] 刘慧青,王丹丹,汤郁,等.脐带间充质干细胞对系统性红斑狼疮患者Th17细胞的调节[J].中华风湿病学杂志,2011,15(7): 439-444.
[2] 王丹丹,张华勇,冯学兵,等.脐带间充质干细胞移植治疗系统性红斑狼疮的临床分析[J].中华风湿病学杂志,2010,14(2):76-79.
[3] 张华勇,冯学兵,马晓蕾,等.异基因骨髓间充质干细胞移植治疗系统性红斑狼疮11例临床分析[J].中华风湿病学杂志,2009,13(2): 89-92.
[4] 杨华强,李红,胡明均,等.脐带间充质干细胞移植治疗系统性红斑狼疮五例并文献复习[J].中华临床医师杂志(电子版),2013,7(14): 6735-6737.
[5] 夏宇欧,王宏.脐带源间充质干细胞移植治疗难治性系统性红斑狼疮[J].中国现代药物应用,2013,7(5):44-45.
[6] 顾菲,冯学兵,王丹丹,等.脐带间充质干细胞移植治疗系统性红斑狼疮合并Stevens-Johnson综合征一例[J].中华风湿病学杂志, 2011,15(2):139-140.
[7] 郭君其,陈建,罗芳,等.自体骨髓间充质干细胞治疗狼疮性肾炎一例[J].中华细胞与干细胞移植(电子版),2009(2):218-219.
[8] 王黎明,周建军,白雯,等.脐带间充质干细胞治疗17例类风湿性关节炎患者的临床疗效观察[J].中国免疫学杂志,2010,26(7): 659-662.
[9] 王秦,李小峰,马丽辉,等.异基因脐带间充质干细胞移植治疗类风湿关节炎疗效及安全性[J].中华临床免疫和变态反应杂志,2011, 5(3):202-206.
[10] [赵成,张华勇,王丹丹,等.异基因骨髓间质干细胞移植治疗难治性类风湿关节炎一例[J].中华风湿病学杂志,2010,14(6): 437-438.
[11] 汤郁,王丹丹,张华勇,等.异基因间充质干细胞移植治疗多发性肌炎/皮肌炎的临床研究[J].中华风湿病学杂志,2011,15(3): 175-178.
[12] 顾菲,张华勇,冯学兵,等.脐带间充质干细胞移植治疗难治性系统性硬化症一例[J].中华风湿病学杂志,2009,13(3):208-209.
[13] Kumar S, Chanda D, Ponnazhagan S. Therapeutic potential of genetically modified mesenchymal stem cells. Gene Ther. 2008;15(10):711-715.
[14] Augello A, Tasso R, Negrini SM, et al. Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis. Arthritis Rheum. 2007;56(4):1175-1186.
[15] González MA, Gonzalez-Rey E, Rico L, et al. Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells. Arthritis Rheum. 2009;60(4):1006-1019.
[16] Asari S, Itakura S, Ferreri K, et al. Mesenchymal stem cells suppress B-cell terminal differentiation. Exp Hematol. 2009; 37(5):604-615.
[17] Spaggiari GM, Capobianco A, Abdelrazik H, et al. Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2. Blood. 2008;111(3): 1327-1333.
[18] Ramasamy R, Fazekasova H, Lam EW, et al. Mesenchymal stem cells inhibit dendritic cell differentiation and function by preventing entry into the cell cycle. Transplantation. 2007; 83(1):71-76.
[19] Bernatsky S, Boivin JF, Joseph L, et al. Mortality in systemic lupus erythematosus. Arthritis Rheum. 2006;54(8):2550- 2557.
[20] Ikehara S, Inaba M, Yasumizu R, et al. Autoimmune diseases as stem cell disorders. Tohoku J Exp Med. 1994;173(1): 141-155.
[21] Sun LY, Zhang HY, Feng XB, et al. Abnormality of bone marrow-derived mesenchymal stem cells in patients with systemic lupus erythematosus. Lupus. 2007;16(2):121-128.
[22] Yang J, Yang X, Chu Y, et al. Identification of Baicalin as an immunoregulatory compound by controlling T(H)17 cell differentiation. PLoS One. 2011;6(2):e17164.
[23] 张光峰,张晓,董光富,等.间充质干细胞联合同种异体骨髓移植治疗狼疮模型鼠的疗效观察[J].中华内科杂志,2008,47(9): 754-757.
[24] Zhou K, Zhang H, Jin O, et al. Transplantation of human bone marrow mesenchymal stem cell ameliorates the autoimmune pathogenesis in MRL/lpr mice. Cell Mol Immunol. 2008; 5(6): 417-424.
[25] Giles JT, Bartlett SJ, Gelber AC, et al. Tumor necrosis factor inhibitor therapy and risk of serious postoperative orthopedic infection in rheumatoid arthritis. Arthritis Rheum. 2006; 55(2): 333-337.
[26] Liu Y, Mu R, Wang S, et al. Therapeutic potential of human umbilical cord mesenchymal stem cells in the treatment of rheumatoid arthritis. Arthritis Res Ther. 2010;12(6):R210.
[27] Marinova-Mutafchieva L, Williams RO, Funa K, et al. Inflammation is preceded by tumor necrosis factor-dependent infiltration of mesenchymal cells in experimental arthritis. Arthritis Rheum. 2002;46(2):507-513.
[28] Holzer U, van Royen-Kerkhof A, van der Torre P, et al. Successful autologous stem cell transplantation in two patients with juvenile dermatomyositis. Scand J Rheumatol. 2010;39(1):88-92.
[29] Ferrara JL, Levine JE, Reddy P, et al. Graft-versus-host disease. Lancet. 2009;373(9674):1550-1561.
[30] Le Blanc K, Rasmusson I, Sundberg B, et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet. 2004; 363(9419):1439-1441. |